Calcitonin kinetics in the early postoperative period of medullary thyroid carcinoma

Langenbeck's Archives of Surgery

Volumn 386, Issue 6, 2001, Pages 434-439

  Brauckhoff, Michael ^a   Gimm, Oliver ^a   Brauckhoff, Katrin ^a   Ukkat, Jörg ^a   Thomusch, Oliver ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Kinetics of calcitonin; Medullary thyroid carcinoma; Prognostic impact

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; LYMPH NODE METASTASIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; THYROID MEDULLARY CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; HUMANS; POSTOPERATIVE PERIOD; PROGNOSIS; THYROID NEOPLASMS; TIME FACTORS;

EID: 0035211473     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230100252     Document Type: Article

References (20)

1. Zaidi M, Moonga BS, Bevis PJR, Towhidul Alam ASM, Legon S, Wimalawansa S et al (1991) Expression and function of the calcitonin gene products. Vitam Horm 46:87-164
2. Engelbach M, Gorges R, Forst T, Pfutzner A, Dawood R, Heerdt S et al (2000) Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements. J Clin Endocrinol Metab 85:1890-1894
3. Grauer A, Raue F, Ziegler R (1998) Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes 106:353-359
4. Guilloteau D, Perdrisot R, Calmettes C. Baulieu JL, Lecomte P, Kaphan G et al (1990) Diagnosis of medullary carcinoma of the thyroid (MTC) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MTC. J Clin Endocrinol Metab 71:1064-1067
5. Perdrisot R, Bigorgne JC, Guilloteau D, Jallet P (1990) Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma. Clin Chem 36:381-383
6. Wells SA Jr, Ontjes DA, Cooper CW. Hennessy JF. Ellis GJ, McPherson HT et al (1975) The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II. Ann Surg 182:362-370
7. Stepanas AV. Samaan NA, Hill CS Jr, Mickey RC (1979) Medullary thyroid carcinoma: importance of serial serum calcitonin measurement. Cancer 43:825-837
8. Tisell LE, Dilley WG, Wells SA Jr (1996) Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 119:34-39
9. Fugazzola L, Pinchera A, Luchetti F, lacconi P, Miccoli P, Romei C et al (1994) Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma. Int J Biol Markers 9:21-24
10. Girelli ME, Dotto S, Nacamulli D, Piccolo M, De Vido D, Russo T et al ( 1994) Prognostic value of early postoperative calcitonin level in medullary thyroid carcinoma. Tumori 80:113-117
11. Gimm O, Ukkat J, Dralle H ( 1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22:562-568
12. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U. Dralle H (2000) Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88:1909 -1915
13. Hinze R, Holzhausen HJ. Gimm O. Dralle H. Rath FW (1998) Primary hereditary medullary thyroid carcinoma C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch 433:203-208
14. Miyauchi A, Onishi T, Morimoto S. Takai S, MatsuJ.uka F, Kuma K et al (1984) Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Ann Surg 199:461-466
15. Ardaillou R, Sizonenko P, Meyrier A, Vallée G, Beaugas C (1970) Metabolie clearance rate of radioiodinated human calcitonin in man. J Clin Invest 49:2345-2352
16. Henriksen JH, Schifter S, Moller S, Bendtsen F (2000) Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin generelated peptide. Metabolism 49:47-52
17. Engelbach M, Heerdt S, Gorges R, Kunt T, Pfutzner A, Forst T et al (1998) Is there an ectopic secretion of monomeric calcitonin in the human being? Langenbecks Arch Surg 383:456-459
18. Machens A, Haedecke J, Holzhausen HJ, Thomusch O, Schneyer U, Dralle H (2000) Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation. Langenbecks Arch Surg 38:398-401
19. Guliana JM, Taboulet J, Calmettes C, Milhaud G, Moukhtar MS, Jullienne A (1994) Heterogeneity of circulating calcitonin levels: relations with calcitonin biosynthesis in medullary thyroid carcinomas. Nucl Med Biol 21:359-368
20. van Heerden JA, Grant CS. Gharib H, Hay ID. Ilstrup DM (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395-401